Fmoc-R-3-amino-4-(3-trifluoromethylphenyl)-butyric acid, 97%, 250mg

1-(Pyrimidin-2-yl)-1H-pyrazol-4-amine, 95.0%, 50mg

(3,4-Dichlorophenyl)(phenyl)methanamine hydrochloride, 98%, 5g

1-[2-(2-fluorophenoxy)ethyl]-1H-indole-3-carbaldehyde, 95.0%, 1g

8-HYDROXYQUINOLINE-5-CARBOXYLIC ACID, 99.0%, 100mg

Embudos dosificadores con tapón de PTFE, 100 ml, 19/26, 1 unidad

6-Bromo-2-phenylimidazo[1,2-a]pyridine, 95.0%, 1g

cis-3-((tert-Butoxycarbonyl)amino)cyclobutanecarboxylic acid, 95.0%, 250mg

Símbolo de advertencia según ISO 7010 en el rollo, Rayo láser, Longitud lateral 25 mm, 1 Rollo

3-Methyl-1-butanol, 99.0%, 500ml

N-4-NITROBENZENE SULFONYL-O-BENZYLHYDROXYLAMINE, 95.0%, 1g

TERT-BUTYL 3-(1-AMINO-2-METHOXY-2-OXOETHYL)AZETIDINE-1-CARBOXYLATE, 95.0%, 500mg

4-((2-Nitrophenyl)amino)phenol, 98% GC, 5g